 | Up a level |
Zürcher, Sven; Martignoni, Zora; Hunger, Robert; Benzaquen, Michael; Seyed Jafari, S Morteza (2024). Mohs Micrographic Surgery for Cutaneous Squamous Cell Carcinoma. Cancers, 16(13) MDPI AG 10.3390/cancers16132394
Bertschi, Nicole L; Steck, Oliver; Luther, Fabian; Bazzini, Cecilia; von Meyenn, Leonhard; Schärli, Stefanie; Vallone, Angela; Felser, Andrea; Keller, Irene; Friedli, Olivier; Freigang, Stefan; Begré, Nadja; Radonjic-Hoesli, Susanne; Lamos, Cristina; Gabutti, Max Philip; Benzaquen, Michael; Laimer, Markus; Simon, Dagmar; Nuoffer, Jean-Marc and Schlapbach, Christoph (2023). PPAR-γ regulates the effector function of human T helper 9 cells by promoting glycolysis. Nature Communications, 14(1), p. 2471. Springer Nature 10.1038/s41467-023-38233-x
Haykal, Diala; Cartier, Hugues; Benzaquen, Michael; Damiani, Giovanni; Habib, Sayed Meelad (2023). The growing importance of ultrasonography in cosmetic dermatology: An update after the 23rd IMCAS Annual World Congress (2022). Journal of cosmetic dermatology, 22(1), pp. 222-225. Blackwell Science 10.1111/jocd.15503
Imstepf, Valentina A; Schlapbach, Christoph; Benzaquen, Michael; Feldmeyer, Laurence; Lipsker, Dan; Borradori, Luca (2022). Localized aseptic neutrophilic dermatoses of the extremities triggered by stasis and tissue damage: Two case reports of an unrecognized condition misdiagnosed as bacterial cellulitis. JAAD case reports, 28, pp. 14-17. Elsevier 10.1016/j.jdcr.2022.07.036
Benzaquen, Michael; Munshi, Mohammad; Bossart, Simon; Feldmeyer, Laurence; Emelianov, Vladimir; Yawalkar, Nikhil; Cazzaniga, Simone; Heidemeyer, Kristine (2022). Long-Term Dose Optimization of Adalimumab via Dose Spacing in Patients with Psoriasis. Bioengineering, 9(8) MPDI 10.3390/bioengineering9080387
Benzaquen, Michael; Fongue, Jessica; Pauly, Vanessa; Collet-Villette, Anne-Marie (2021). Laser-Assisted Hyaluronic Acid Delivery by Fractional Carbon Dioxide Laser in Facial Skin Remodeling: A Prospective Randomized Split-Face Study in France. Lasers in surgery and medicine, 53(9), pp. 1166-1172. Wiley 10.1002/lsm.23403
Delaunay, Pascal; Benzaquen, Michael; Berenger, Jean-Michel; Parola, Philippe (2020). Bed bug bites. Dermatologic therapy, 33(6), e14341. Wiley-Blackwell 10.1111/dth.14341
Barré, Mathilde; Delaporte, Emmanuel; Berbis, Philippe; Benzaquen, Michael (2020). Severe dermatomyositis revealing a thymic carcinoma: Did rituximab delay the diagnosis? Dermatologic therapy, 33(6), e14016. Wiley-Blackwell 10.1111/dth.14016
Benzaquen, Michael; Yawalkar, Nikhil; Feldmeyer, Laurence; Borradori, Luca; Schlapbach, Christoph (2020). Herpetiform aphthous ulcerations induced by secukinumab: Report of 2 cases. JAAD case reports, 6(10), pp. 1107-1109. Elsevier 10.1016/j.jdcr.2020.08.028
Benzaquen, Michael (2020). Update on the anti-programmed cell death-1 receptor antibodies in advanced cutaneous squamous-cell carcinoma. Dermatologic therapy, 33(3), e13325. Wiley-Blackwell 10.1111/dth.13325
Benzaquen, Michael; Borradori, Luca; Cazzaniga, Simone; Berbis, Philippe; Feldmeyer, Laurence (2018). Reply to: "Bullous pemphigoid and diabetes mellitus: Are we missing the larger picture?". Journal of the American Academy of Dermatology, 79(2), e29-e30. Elsevier 10.1016/j.jaad.2018.03.049
Benzaquen, Michael; Borradori, Luca; Berbis, Philippe; Cazzaniga, Simone; Valero, René; Richard, Marie-Aleth; Feldmeyer, Laurence (2018). Dipeptidyl peptidase-IV inhibitors, a risk factor for bullous pemphigoid. Retrospective multicenter case-control study in France and Switzerland. Journal of the American Academy of Dermatology, 78(6), pp. 1090-1096. Elsevier 10.1016/j.jaad.2017.12.038
Bertschi, Nicole L; Steck, Oliver; Luther, Fabian; Bazzini, Cecilia; von Meyenn, Leonhard; Felser, Andrea; Keller, Irene; Friedli, Olivier; Freigang, Stefan; Begré, Nadja; Lamos, Cristina; Gabutti, Max Philip; Benzaquen, Michael; Laimer, Markus; Simon, Dagmar; Nuoffer, Jean-Marc; Schlapbach, Christoph (16 August 2022). PPAR-γ regulates the effector function of human TH9 cells by promoting glycolysis (bioRxiv). Cold Spring Harbor Laboratory 10.1101/2022.08.16.503972
